🔎 Trials Near Me

Domov › Akutna bifentipska levkemija › Kalifornija

Klinične študije za Akutna bifentipska levkemija v Kalifornija

15 študij za Akutna bifentipska levkemija išče udeležence na lokacijah v Kalifornija.

Mesta v Kalifornija

Uradno besedilo študije (angleško)

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

  • City of Hope, Duarte
  • UC Davis, Sacramento
  • Stanford Health Care, Stanford
Vključevanje udeležencevFaza 1
Starost 12–78 · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT03802695

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

  • Loma Linda University Medical Center, Loma Linda
  • Miller Children's and Women's Hospital Long Beach, Long Beach
  • UCSF Benioff Children's Hospital Oakland, Oakland
  • in še 4
Vključevanje udeležencevFaza 2
365 Days · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06317662

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

  • Kaiser Permanente Downey Medical Center, Downey
  • City of Hope Comprehensive Cancer Center, Duarte
  • Loma Linda University Medical Center, Loma Linda
  • in še 14
Vključevanje udeležencevFaza 3
365 Days – 25 Years · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT03959085

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  • Kaiser Permanente Downey Medical Center, Downey
  • Loma Linda University Medical Center, Loma Linda
  • Miller Children's and Women's Hospital Long Beach, Long Beach
  • in še 8
Vključevanje udeležencevFaza 1/2
Do 22 let · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT04726241

Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)

  • Rady Children's Hospital, San Diego
Vključevanje udeležencevFaza 2
Starost 1–18 · Vsi spoli · Posodobljeno 10. avg. 2026 · NCT06390319

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

  • City of Hope, Duarte
  • Valkyrie Clinical Trials, Los Angeles
Vključevanje udeležencevFaza 1/2
Starost 13–90 · Vsi spoli · Posodobljeno 6. avg. 2026 · NCT06533579

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

  • Rady Children's Hospital, San Diego
Vključevanje udeležencevFaza 1
Starost 1–30 · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT06177067

Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

  • Rady Children's Hospital, San Diego
Vključevanje udeležencevFaza 4
Starost 1–18 · Vsi spoli · Posodobljeno 14. jul. 2026 · NCT06289673

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

  • UCLA Department of Medicine, Los Angeles
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 7. jul. 2026 · NCT07216443

Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT

  • Stanford University, Palo Alto
Vključevanje udeležencevFaza 1
Starost 18–70 · Vsi spoli · Posodobljeno 23. jun. 2026 · NCT06551584

A Study of Revumenib and Mezigdomide in People With Leukemia

  • City of Hope Cancer Center (Data collection only), Duarte
Vključevanje udeležencevFaza 1/2
Starost 12 in več · Vsi spoli · Posodobljeno 22. jun. 2026 · NCT07356154

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

  • City of Hope, Duarte
  • Los Angeles Cancer Network, Los Angeles
  • UCLA Medical Center of Hematology/Oncology, Los Angeles
  • in še 1
Vključevanje udeležencevFaza 1/2
Starost 12–95 · Vsi spoli · Posodobljeno 15. apr. 2026 · NCT04329728

Venetoclax Basket Trial for High Risk Hematologic Malignancies

  • University of California San Francisco-Benioff Children's Hospital, San Francisco
Vključevanje udeležencevFaza 1
Starost 1–40 · Vsi spoli · Posodobljeno 12. mar. 2026 · NCT05292664

Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant

  • City of Hope Medical Center, Duarte
Vključevanje udeležencevFaza 1
Starost 2 in več · Vsi spoli · Posodobljeno 5. mar. 2026 · NCT06575296

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  • Children's Hospital Los Angeles, Los Angeles
  • Children's Hospital Orange County, Orange
  • UCSF School of Medicine, San Francisco
Vključevanje udeležencevFaza 1
Starost 1–21 · Vsi spoli · Posodobljeno 6. dec. 2024 · NCT05476770

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.